Welcome, this website is intended for international healthcare professionals with an interest in the treatment of Advanced Prostate Cancer. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here


Christopher P. Evans

2 Linking Laboratory Science to the Clinic - Keynote, Christopher P. Evans

Advanced prostate carcinoma is characterized by a marked heterogeneity at the inter-patient, intra-patient and intra-tumor level. Genomic techniques have provided insight into the molecular profile of prostate cancer and this perspective will impact patient care as Professor Christopher Evans, UC Davis School of Medicine Sacramento, California, illustrates on the example of the PREVAIL study with enzalutamide and the COU-AA-301 trial with abiraterone.